May 17, 2012
Bayer Corp. has agreed to pay $15 million to resolve class action claims that it misled consumers into believing its combination aspirin drugs had received regulatory approval, according to a settlement motion filed in New York federal court Wednesday.
September 16, 2009
Bayer Healthcare LLC has asked a federal judge in New York to scrap a multidistrict litigation case that accuses the pharmaceutical giant of illegally marketing its combination aspirins as a way to fend off heart and bone disease.
July 13, 2009
Consumers accusing Bayer Healthcare LLC of promoting its aspirin products without regulatory approval have banded together in multidistrict litigation, filing a master complaint alleging the pharmaceutical giant illegally marketed its combination aspirins as a way to fend off heart and bone disease.